FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–$MD–Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.35 per share for the three months ended September 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.40. For … [Read more…]
Net revenue of $55.8 million for Q3 2022; including $30.0 million milestone from Otsuka related to European Approval of LUPKYNIS® (voclosporin) Adjusts net product revenue guidance to $100-105 million from sales of LUPKYNIS for 2022 Issues preliminary net product revenue guidance for 2023 in the range of $120-140 million from sales of LUPKYNIS Approximately $400 … [Read more…]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes as Chief Financial Officer (CFO). Mr. Malkomes joins the executive leadership team to lead Cardior’s financial operations and planning, risk and compliance, investor relations and information technology (IT) as the … [Read more…]
The company, founded by Matthieu Courtecuisse, announces the creation of a Life Science Consulting division, focused on supporting pharmaceutical, biotech, medical device, diagnostic and animal health industry and financial players. With the acquisition of Latham BioPharm Group, nearly 60 life science consultants become immediately available in the United States. The goal is to reach 200 … [Read more…]
All seven global companies’ near-term targets aligned to the 1.5°C pathway Endorsement of commitments and action by health systems partners LONDON–(BUSINESS WIRE)–#COP27–CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi today announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems. For the … [Read more…]
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2022 financial results on Tuesday, November … [Read more…]
Completed $87 Million in New Investments HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended September 30, 2022. THIRD QUARTER 2022 AND OTHER HIGHLIGHTS Net income for the quarter of $105 million, or $0.43 per common share, compared to $143 million, or $0.58 … [Read more…]
Highlights Net business wins in the quarter of $2,351 million; a net book to bill of 1.21, and 1.24 on a trailing twelve month basis. Closing backlog of $20.2 billion, an increase of 1.3% on Q2 2022 or an increase of 9.0% on Q3 2021. Quarter 3 revenue of $1,942.4 million representing an increase of … [Read more…]
INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16, at 10:00 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a webcast of the presentation by visiting www.elevancehealth.com and selecting the … [Read more…]
EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced third quarter 2022 financial results. Third Quarter 2022 Summary Total revenue for the third quarter of 2022 was $13.5 million, an increase of 4.4% over the second quarter of 2022 U.S. disposables revenue of $9.5 million reflects a 19.6% increase over U.S. disposables … [Read more…]
